← Back to headlines
Alkermes Narcolepsy Drug Shows Positive Phase 2 Trial Results
Alkermes announced positive results from its Phase 2 clinical trial for a narcolepsy drug, indicating potential efficacy for the treatment.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
